Harvard Medical School, Massachusetts General Hospital, and Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Annu Rev Pharmacol Toxicol. 2012;52:433-53. doi: 10.1146/annurev-pharmtox-010611-134751. Epub 2011 Oct 19.
As the current paradigms of drug discovery evolve, it has become clear that a more comprehensive understanding of the interactions between small molecules and organismal biology will be vital. The zebrafish is emerging as a complement to existing in vitro technologies and established preclinical in vivo models that can be scaled for high-throughput. In this review, we highlight the current status of zebrafish toxicology studies, identify potential future niches for the model in the drug development pipeline, and define the hurdles that must be overcome as zebrafish technologies are refined for systematic toxicology.
随着当前药物发现模式的发展,人们越来越清楚地认识到,更全面地了解小分子与生物有机体内在相互作用将是至关重要的。斑马鱼正在成为现有体外技术和已建立的临床前体内模型的补充,可进行高通量筛选。在这篇综述中,我们强调了斑马鱼毒理学研究的现状,确定了该模型在药物开发管道中的潜在未来利基,并定义了在为系统毒理学优化斑马鱼技术时必须克服的障碍。